Target intelligence / Profile preview

LLPH divergent transcript (LLPH-DT)

Target
LLPH-DT
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Divergent transcript
01

Overview

LLPH divergent transcript (LLPH-DT) is an antisense long noncoding RNA gene located adjacent to the LLPH protein-coding gene in a head-to-head orientation, producing a transcript that runs antisense to LLPH mRNA. Like other divergent antisense transcripts, LLPH-DT may regulate the expression of its neighboring gene (LLPH) and participate in broader epigenetic and transcriptional processes. Antisense RNAs frequently influence gene activity by modulating chromatin, transcription initiation, and interfering with mRNA stability. While the specific biological and disease roles of LLPH-DT remain poorly characterized, the family of antisense long noncoding RNAs is increasingly recognized for its potential impacts on cellular regulation, imprinting, and disease susceptibility. No drugs or clinical biomarkers are currently associated with LLPH-DT, and it is not presently considered a canonical therapeutic target.

Other names
LLPH-AS1LLPH antisense RNA 1 (head to head)LLPH-DT
02

Mechanism of action

Not directly applicable; as a lncRNA, possible mechanisms include modulation of chromatin state, transcriptional interference, and recruitment of epigenetic regulators to the LLPH locus or its neighboring genes

03

Biological functions

Regulation of gene expression (especially transcriptional and post-transcriptional regulation)Chromatin modification and epigenetic regulation (common among antisense RNAs)Possible roles in transcriptional interference (affecting nearby gene promoter activity by antisense transcription)Cellular regulatory networks
04

Disease associations

Potential implications in cancer, neurological function, or imprinting depending on context (annotation databases do not specify strong direct disease associations for LLPH-DT specifically)

Beyond the preview

Go deeper on LLPH divergent transcript (LLPH-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LLPH divergent transcript (LLPH-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call